CB vs OGEN · P/E 14, rev $59.40B vs rev $37.7K
Chubb Ltd (CB) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the CB and OGEN stock pages for the full models.
Not investment advice.